Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$799
|
$753B |
14.2x |
35.2x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$192
|
$403B |
6.9x |
15.2x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$157
|
$391B |
4.3x |
11.9x |
Novo Nordisk
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 443
|
$323B |
6.6x |
13.1x |
Roche
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Imaging & Diagnostics
|
CHF 260
|
$284B |
3.7x |
9.3x |
Novartis
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 96
|
$264B |
4.7x |
11.5x |
AstraZeneca
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£107
|
$252B |
4.3x |
12.4x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$84
|
$236B |
3.7x |
8.4x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$297
|
$208B |
6.0x |
11.1x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$25
|
$188B |
3.0x |
7.7x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$112
|
$156B |
5.4x |
12.2x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$47
|
$136B |
2.9x |
10.8x |
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€83
|
$134B |
2.5x |
8.5x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$472
|
$117B |
10.1x |
35.5x |
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£14
|
$97.6B |
2.3x |
6.6x |
Takeda Pharmaceuticals
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4361
|
$76.1B |
2.4x |
9.3x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$156
|
$74.3B |
7.9x |
18.4x |
Chugai Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 6884
|
$71.9B |
8.7x |
17.4x |
Bayer
|
Germany |
Biopharmaceuticals,
Agriculture,
Drug Development & Therapeutics,
Health & Beauty
|
€27
|
$70.1B |
1.3x |
6.1x |
Merck KGaA
|
Germany |
Biopharmaceuticals,
Drug Development & Therapeutics,
Advanced Materials
|
€113
|
$66.1B |
2.6x |
9.2x |
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$571
|
$56.0B |
4.1x |
11.3x |
Haleon
|
United Kingdom of Great Britain and Northern Ireland |
Health & Beauty,
Drug Development & Therapeutics
|
£4
|
$55.8B |
3.7x |
14.6x |
Jiangsu Hengrui
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 58
|
$50.0B |
11.9x |
44.2x |
Sun Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1683
|
$44.4B |
7.1x |
24.8x |
Fresenius
|
Germany |
Hospitals & Clinics,
Medical Supplies,
Drug Development & Therapeutics
|
€42
|
$40.9B |
1.6x |
9.5x |
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$316
|
$39.8B |
15.2x |
216.5x |
Galderma Group
|
Switzerland |
Health & Beauty,
Drug Development & Therapeutics
|
CHF 125
|
$39.7B |
8.1x |
35.1x |
Daiichi Sankyo
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 3338
|
$38.7B |
2.9x |
14.0x |
Teva Pharmaceuticals
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ILS 56
|
$35.1B |
2.0x |
6.9x |
argenx
|
Belgium |
Drug Development & Therapeutics
|
€487
|
$31.8B |
10.0x |
70.5x |
Sandoz
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 45
|
$28.1B |
2.5x |
12.2x |
BeOne Medicines
|
Hong Kong |
Drug Development & Therapeutics
|
HKD 160
|
$27.2B |
6.1x |
-492.6x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$24.2B |
1.7x |
5.6x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$133
|
$23.5B |
2.5x |
7.4x |
Otsuka Holdings
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
JPY 6620
|
$22.9B |
1.4x |
6.2x |
Bausch Health
|
Canada |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Health & Beauty
|
CAD 9
|
$22.9B |
2.3x |
6.5x |
Astellas Pharma
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 1440
|
$22.1B |
1.7x |
8.7x |
Hansoh Pharma
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 33
|
$21.4B |
11.9x |
31.9x |
Divi's Laboratories
|
India |
Contract Research & Manufacturing,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 6779
|
$20.6B |
18.0x |
55.5x |
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$102
|
$19.3B |
46.2x |
-20.9x |
Grifols
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€10
|
$19.1B |
2.2x |
8.9x |
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$25
|
$18.5B |
N/A |
-71.2x |
Innovent Biologics
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 82
|
$17.2B |
11.6x |
268.9x |
Zhangzhou Pientzehuang
|
China |
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
CNY 198
|
$16.6B |
10.7x |
31.5x |
Sichuan Biokin
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 284
|
$15.8B |
29.5x |
70.6x |
Torrent Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 3405
|
$13.8B |
9.9x |
30.2x |
Mankind Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
INR 2700
|
$13.7B |
9.0x |
35.7x |
Sino Biopharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 6
|
$13.1B |
3.1x |
13.5x |
Akeso
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 118
|
$13.0B |
32.2x |
-2599.4x |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$135
|
$12.9B |
5.1x |
21.3x |
Cipla
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1485
|
$12.8B |
3.9x |
15.3x |
Dr. Reddy's Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1251
|
$12.0B |
3.1x |
11.7x |
Sobi
|
Sweden |
Biopharmaceuticals,
Drug Development & Therapeutics
|
SEK 295
|
$12.0B |
4.2x |
11.5x |
Fosun Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
CNY 24
|
$11.6B |
2.0x |
12.4x |
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$70
|
$11.2B |
2.5x |
16.5x |
Ascendis Pharma
|
Germany |
Drug Development & Therapeutics
|
€150
|
$11.0B |
N/A |
N/A |
Orion
|
Finland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€66
|
$11.0B |
5.8x |
18.2x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$11.0B |
1.7x |
5.6x |
Zydus Lifesciences
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 969
|
$10.8B |
3.9x |
13.3x |
CSPC Pharma Group
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 8
|
$10.5B |
2.6x |
10.4x |
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$111
|
$10.5B |
3.9x |
-7.2x |
BioMarin Pharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$58
|
$10.5B |
3.5x |
13.4x |
Lupin
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1925
|
$10.4B |
3.8x |
15.8x |
BridgeBio Pharma
|
United States of America |
Drug Development & Therapeutics
|
$48
|
$10.4B |
29.1x |
-22.2x |
Shionogi
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
JPY 2488
|
$10.3B |
3.3x |
8.2x |
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$298
|
$10.3B |
3.4x |
6.3x |
Genmab
|
Denmark |
Drug Development & Therapeutics,
Biopharmaceuticals
|
DKK 1372
|
$10.2B |
2.9x |
8.2x |
Ipsen
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€106
|
$10.0B |
2.4x |
6.7x |
Kelun-Biotech
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 343
|
$9.8B |
35.7x |
-221.4x |
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$111
|
$9.6B |
2.3x |
7.3x |
Blueprint Medicines
|
United States of America |
Drug Development & Therapeutics
|
$129
|
$8.2B |
13.2x |
-78.1x |
Abbott India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Nutraceuticals & Cosmeceuticals
|
INR 34389
|
$8.2B |
10.7x |
39.8x |
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$58
|
$7.9B |
6.9x |
10.9x |
Aurobindo Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1139
|
$7.7B |
2.0x |
9.7x |
CR Pharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics,
Pharmacies
|
HKD 5
|
$7.7B |
0.2x |
3.5x |
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$33
|
$7.5B |
2.9x |
-2.0x |
Kyowa Kirin
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2475
|
$7.5B |
2.2x |
9.6x |
Glenmark Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 2218
|
$7.4B |
4.6x |
25.4x |
Corcept Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$73
|
$7.4B |
9.3x |
N/A |
Regencell Bioscience
|
United States of America |
Drug Development & Therapeutics
|
$15
|
$7.3B |
N/A |
N/A |
Lundbeck
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 34
|
$7.2B |
N/A |
N/A |
Eisai Co.
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 3958
|
$7.2B |
1.3x |
10.7x |
Hikma Pharmaceuticals
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£20
|
$7.0B |
2.1x |
8.0x |
Perrigo
|
United States of America |
Health & Beauty,
Drug Development & Therapeutics
|
$27
|
$7.0B |
1.6x |
9.2x |
Legend Biotech
|
United States of America |
Drug Development & Therapeutics
|
$39
|
$6.6B |
7.9x |
-44.6x |
Alkem Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 4841
|
$6.4B |
4.1x |
21.1x |
Madrigal Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$320
|
$6.4B |
14.3x |
-14.6x |
Krka
|
Slovenia |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€199
|
$6.4B |
2.8x |
10.1x |
Yuhan
|
South Korea |
Biopharmaceuticals,
Drug Development & Therapeutics
|
KRW 111195
|
$6.1B |
3.9x |
56.4x |
TG Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$39
|
$6.1B |
13.1x |
55.2x |
Ionis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$43
|
$6.0B |
8.3x |
-13.4x |
GSK India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Health & Beauty
|
INR 3187
|
$6.0B |
13.4x |
42.3x |
Beijing Tongrentang Co
|
China |
Drug Development & Therapeutics
|
CNY 36
|
$5.8B |
2.1x |
13.0x |
Rhythm Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$89
|
$5.7B |
37.0x |
-26.4x |
Shanghai Allist
|
China |
Drug Development & Therapeutics
|
CNY 99
|
$5.7B |
9.8x |
23.0x |
Humanwell Healthcare
|
China |
Drug Development & Therapeutics,
Medical Devices
|
CNY 21
|
$5.6B |
1.5x |
9.0x |
Laurus Labs
|
India |
Drug Development & Therapeutics
|
INR 824
|
$5.5B |
8.1x |
40.4x |
Axsome Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$112
|
$5.4B |
10.8x |
-29.8x |
Lantheus Holdings
|
United States of America |
Medical Imaging & Diagnostics,
Drug Development & Therapeutics
|
$83
|
$5.4B |
3.5x |
7.9x |
SK Biopharmaceuticals
|
South Korea |
Drug Development & Therapeutics
|
KRW 95600
|
$5.4B |
11.8x |
52.3x |